Upstream process intensification and continuous manufacturing
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Manufacturing process of biopharmaceuticals usually starts from culturing recombinant protein producing cells, predominately Chinese Hamster Ovary (CHO) cells, in bioreactors. Currently, fed-batch cell culture process is the most common upstream process method due to its operational simplicity and industrial familiarity. Intensified cell culture process, enabled by perfusion and other technologies, offers many benefits over traditional fed-batch cell culture mode. In this review, we discuss the current state-of-art for upstream cell culture process intensification with a focus towards continuous manufacturing. We also explore key technical drivers and their roles in steering towards a more cost-effective and flexible upstream biomanufacturing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Production of recombinant protein therapeutics in cultivated mammalian cells
Wurm, F. M. (2004) · Nature Biotechnology · doi:10.1038/nbt1026 · Cited by 2,032
The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line
Xu, X., Nagarajan, H., Lewis, N. E., Pan, S., Cai, Z., Liu, X., Chen, W., Xie, M., Wang, W., Hammond, S., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1932 · Cited by 785
Abu‐Absi, N. R., Kenty, B. M., Cuellar, M. E., Borys, M. C., Sakhamuri, S., Strachan, D. J., Hausladen, M. C., & Li, Z. J. (2011) · Biotechnology and Bioengineering · doi:10.1002/bit.23023 · Cited by 322
Karst, D. J., Serra, E., Villiger, T. K., Soos, M., & Morbidelli, M. (2016) · Biochemical Engineering Journal · doi:10.1016/j.bej.2016.02.003 · Cited by 151
Near Infrared Spectroscopy for Bioprocess Monitoring and Control: Current Status and Future Trends
Scarff, M., Arnold, S. A., Harvey, L. M., & McNeil, B. (2006) · Critical Reviews in Biotechnology · doi:10.1080/07388550500513677 · Cited by 124
Addition of Valproic Acid to CHO Cell Fed-Batch Cultures Improves Monoclonal Antibody Titers
Yang, W. C., Lu, J., Nguyen, N. B., Zhang, A., Healy, N. V., Kshirsagar, R., Ryll, T., & Huang, Y.-M. (2014) · Molecular Biotechnology · doi:10.1007/s12033-013-9725-x · Cited by 89
Guez, J. S., Cassar, J. P., Wartelle, F., Dhulster, P., & Suhr, H. (2004) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2004.04.028 · Cited by 64
Cited by
Modern Sensor Tools and Techniques for Monitoring, Controlling, and Improving Cell Culture Processes
Reyes, S. J., Durocher, Y., Pham, P. L., & Henry, O. (2022) · Processes · doi:10.3390/pr10020189 · Cited by 130
Bioprocessing 4.0 in Biomanufacturing: Paving the Way for Sustainable Bioeconomy
Pandey, K., Pandey, M., Kumar, V., Aggarwal, U., & Singhal, B. (2024) · Systems Microbiology and Biomanufacturing · doi:10.1007/s43393-023-00206-y · Cited by 58
“Upstream process intensification is being used to enhance the production and quality of bioproducts [24].”
Yilmaz, D., Mehdizadeh, H., Navarro, D., Shehzad, A., O'Connor, M., & McCormick, P. (2020) · Biotechnology Progress · doi:10.1002/btpr.2947 · Cited by 51
Model-based intensification of CHO cell cultures: One-step strategy from fed-batch to perfusion
Richelle, A., Corbett, B., Agarwal, P., Vernersson, A., Trygg, J., & McCready, C. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.948905 · Cited by 22
Perfusion‐Based Production of rAAV via an Intensified Transient Transfection Process
Nguyen, T. N. T., Park, D., Canova, C. T., Sangerman, J., Srinivasan, P., Ou, R. W., Barone, P. W., Neufeld, C., Wolfrum, J. M., Springs, S. L., et al. (2025) · Biotechnology and Bioengineering · doi:10.1002/bit.28967 · Cited by 10
“Upstream process intensification techniques such as continuous perfusion and high cell density culture are frequently used to manufacture legacy biopharmaceuticals such as monoclonal antibodies (Chen et al. 2018; Konstantinov and Cooney 2015).”
Metadata
- Authors
- Chen, C., Wong, H. E., & Goudar, C. T.
- Venue
- Current Opinion in Chemical Engineering
- Publisher
- Elsevier BV
- Published
- 2018-12
- Volume
- 22
- Pages
- 191-198
- ISSN
- 2211-3398 (ISSN-L)
- OpenAlex
- W2901614545
- Cited by
- 101
- References
- 7
- FWCI
- 0.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Upstream process intensification and continuous manufacturing. https://app.cochat.ai/papers/10.1016/j.coche.2018.10.006
- The paper
- Chen, C., Wong, H. E., & Goudar, C. T. (2018). Upstream process intensification and continuous manufacturing. Current Opinion in Chemical Engineering. https://doi.org/10.1016/j.coche.2018.10.006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.